Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$204K Buy
+484
New +$193K 0.08% 75
2025
Q2
– Sell
-3,241
Closed -$1.01M – 51
2025
Q1
$1.01M Buy
+3,241
New +$957K 0.52% 32
2023
Q1
– Sell
-115
Closed -$30.2K – 40
2022
Q4
$30.2K Buy
115
+5
+5% +$1.34K 0.01% 64
2022
Q3
$25K Sell
110
-80
-42% -$19.4K 0.01% 48
2022
Q2
$47K Buy
190
+71
+60% +$17.4K 0.09% 43
2022
Q1
$29K Buy
+119
New +$27.3K 0.01% 93

Other funds holding AMGN

Win Advisors's AMGN Position: Q3 2026 in Review

Win Advisors opened a new position in Amgen (AMGN) in Q3 2026: 484 shares worth $204K. The stake represents 0.08% of the portfolio and ranks #75 among its holdings. This is a return to the name: Win Advisors previously reported a position in AMGN as recently as Q1 2025.

Win Advisors first reported a position in AMGN in Q1 2022 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Win Advisors held 484 shares of Amgen worth $204K as of Q3 2026.
  • Amgen was a new Win Advisors position in Q3 2026.
  • Amgen made up 0.08% of Win Advisors's portfolio in Q3 2026, its #75 holding.
  • Win Advisors first reported a position in Amgen in Q1 2022 and has held it in 6 quarters since.
  • Win Advisors's Amgen position peaked at $1.01M in Q1 2025.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Win Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.